14 May 2022>: Clinical Research
Case-Control Study to Investigate the Association Between Serum Apolipoprotein B/A1 Ratio and Atrial Fibrillation by Sex in 920 Patients from China
Xia Zhong 1ACE , Huachen Jiao 2DFG* , Dongsheng Zhao 1BC , Jing Teng 1AF , Mengqi Yang 1BEDOI: 10.12659/MSM.936425
Med Sci Monit 2022; 28:e936425
Table 4 Differences in serum APOB/APOA1 ratio by different subtypes, complications, and statins use in patients with atrial fibrillation.
Variable | n | APOB/APOA1 ratio | P value |
---|---|---|---|
Subtypes of AF | |||
Paroxysmal AF | 320 | 0.78±0.58 | 0.082 |
Permanent AF | 600 | 0.72±0.28 | |
Complications of AF | |||
AF+hypertension | 618 | 0.74±0.47 | 0.296 |
AF+CHD | 812 | 0.74±0.43 | |
AF+diabetes | 274 | 0.79±0.65 | |
Whether or not statins were used | |||
Yes | 605 | 0.73±0.46 | 0.421 |
No | 315 | 0.75±0.29 | |
Data are presented as mean±SD. AF – atrial fibrillation; APOA1 – apolipoprotein A1; APOB – apolipoprotein B; CHD – coronary heart disease. |